Pharmasys Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 31-07-2024
- Paid Up Capital ₹ 1.00 M
as on 31-07-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.29 Cr
as on 31-07-2024
- Revenue -15.15%
(FY 2023)
- Profit -17.80%
(FY 2023)
- Ebitda -19.28%
(FY 2023)
- Net Worth 58.57%
(FY 2023)
- Total Assets -21.79%
(FY 2023)
About Pharmasys
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.29 Cr.
Anil Mediratta and Amit Mediratta serve as directors at the Company.
- CIN/LLPIN
U24304DL2019PTC350978
- Company No.
350978
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2019
- Date of AGM
01 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharmasys?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Mediratta  | Director | 06-Jun-2019 | Current |
| Amit Mediratta | Director | 06-Jun-2019 | Current |
Financial Performance of Pharmasys.
Pharmasys Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.15% decrease. The company also saw a substantial fall in profitability, with a 17.8% decrease in profit. The company's net worth Soared by an impressive increase of 58.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmasys?
In 2023, Pharmasys had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Veritas Life Sciences LimitedActive 19 years 2 months
Anil Mediratta and Amit Mediratta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 21 Mar 2024 | ₹4.29 Cr | Open |
How Many Employees Work at Pharmasys?
Unlock and access historical data on people associated with Pharmasys, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmasys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmasys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
